SCHEMBL22192537

SCHEMBL22192537

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4cc5c6ccccc6n(-c6ccccc6)c5cc4c4ccc5oc6ccccc6c5c43)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ LMNA P02545 1/20 0.35
▸ SIRT2 Q8IXJ6 1/20 0.31
▸ SIRT1 Q96EB6 1/20 0.31
▸ CA12 O43570 1/20 0.31
▸ CA9 Q16790 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ BRCA1 P38398 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22192320 0.97 KDM4E (0.37) KDM4EATML3MBTL1SMN1; SMN2LMNA
SCHEMBL16999824 0.96 SMN1; SMN2 (0.35) KDM4EATML3MBTL1SMN1; SMN2LMNA
SCHEMBL22192503 0.94 L3MBTL1 (0.36) KDM4EATML3MBTL1SMN1; SMN2LMNA
SCHEMBL16999647 0.93 SMN1; SMN2 (0.34) KDM4EATML3MBTL1SMN1; SMN2LMNA
SCHEMBL21018295 0.93 L3MBTL1 (0.33) KDM4EATML3MBTL1SMN1; SMN2LMNA
SCHEMBL15625542 0.92 MAPK1 (0.33) KDM4EATML3MBTL1SMN1; SMN2LMNA
SCHEMBL21018296 0.92 KDM4E (0.32) KDM4EATML3MBTL1SMN1; SMN2LMNA
SCHEMBL22192618 0.92 L3MBTL1 (0.36) KDM4EATML3MBTL1SMN1; SMN2LMNA
SCHEMBL22192336 0.91 SMN1; SMN2 (0.34) KDM4EATML3MBTL1SMN1; SMN2LMNA
SCHEMBL22192322 0.91 SMN1; SMN2 (0.34) KDM4EATML3MBTL1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10703762-B2 Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus IDEMITSU KOSAN CO., LTD. (JP) 2020-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10703762-B2 Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus PIEZO1, OR10J3, EPCAM KDM4E 3529/4885ATM 1283/4885L3MBTL1 2738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback